(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Expression constructs of MECP2 and their cellular localization. (A) Schematic showing the expression constructs of MECP2 that were used in the domain-deletion studies. Deleted residues based on murine MECP2e2 are shown in parentheses. The locations of NLS are shown as red boxes. (B) Cells expressing EGFP-tagged WT and mutant proteins were stained with DAPI and imaged by epifluorescence microscopy. The cellular distribution of the proteins is indicated (N, nuclear; HC, heterochromatin; C, cytoplasmic). (C) Deletion of the MBD results in the mislocalization of MECP2 to the nucleolus. Stable cell lines expressing EGFP-tagged WT and
MBD were immunostained with the nucleolar marker nucleolin and counterstained with DAPI. (D) Cells expressing the
TRD mutant showing both cytoplasmic and nuclear localization. Bars, 5 µm.